SUBSCRIBE
SUBSCRIBE

Indications

PRESS RELEASES
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
March 30, 2026
 · 
6 min read
Press Releases
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
March 26, 2026
 · 
2 min read
Press Releases
Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update
March 26, 2026
 · 
14 min read
Press Releases
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
March 24, 2026
 · 
24 min read
Press Releases
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026
 · 
5 min read
Press Releases
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)
March 23, 2026
 · 
19 min read
Press Releases
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
March 22, 2026
 · 
4 min read
Press Releases
FDA approves Novo Nordisk’s new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile
March 19, 2026
 · 
14 min read
Press Releases
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
March 19, 2026
 · 
11 min read
Press Releases
IDEAYA Biosciences Announces Upcoming Presentations at AACR 2026 Highlighting Multiple Clinical Stage Pipeline Programs
March 19, 2026
 · 
5 min read
Press Releases
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
 · 
18 min read
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
March 16, 2026
 · 
6 min read
Press Releases
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
March 15, 2026
 · 
9 min read
Press Releases
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments
March 13, 2026
 · 
17 min read
Press Releases
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
March 13, 2026
 · 
11 min read
Press Releases
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
March 12, 2026
 · 
5 min read
Press Releases
Piston Bio Announces FDA Alignment on PST-101 Development Program for Cancer-Related Apathy
March 10, 2026
 · 
2 min read
Press Releases
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
March 10, 2026
 · 
9 min read
Press Releases
TECVAYLI®▼ (teclistamab) monotherapy application submitted to the EMA for relapsed/refractory multiple myeloma after at least one prior therapy
March 10, 2026
 · 
12 min read
Press Releases
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
March 9, 2026
 · 
5 min read
Load More